0001872608-24-000001.txt : 20240326 0001872608-24-000001.hdr.sgml : 20240326 20240326162743 ACCESSION NUMBER: 0001872608-24-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20240326 DATE AS OF CHANGE: 20240326 EFFECTIVENESS DATE: 20240326 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Allevion Therapeutics, Inc. CENTRAL INDEX KEY: 0001872608 ORGANIZATION NAME: IRS NUMBER: 852286607 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-508685 FILM NUMBER: 24783992 BUSINESS ADDRESS: STREET 1: 14252 CULVER DRIVE STREET 2: SUITE A-333 CITY: IRVINE STATE: CA ZIP: 92604 BUSINESS PHONE: (949) 701-3545 MAIL ADDRESS: STREET 1: 14252 CULVER DRIVE STREET 2: SUITE A-333 CITY: IRVINE STATE: CA ZIP: 92604 D 1 primary_doc.xml X0708 D LIVE 0001872608 Allevion Therapeutics, Inc. 18001 Cowan, Suite L IRVINE CA CALIFORNIA 92614 (949) 615-7488 DELAWARE None None Corporation true Shahram Moaddeb 18001 Cowan, Suite L Irvine CA CALIFORNIA 92614 Executive Officer Director Promoter Mr. Moaddeb is the founder, chairman of the board and chief executive officer of the company. Jack Wang 18001 Cowan, Suite L Irvine CA CALIFORNIA 92614 Director Mr. Wang serves as a director of the company. Roy Tanaka 18001 Cowan, Suite L Irvine CA CALIFORNIA 92614 Director Mr. Tanaka serves as a director of the company. Dan Dearen 18001 Cowan, Suite L Irvine CA CALIFORNIA 92614 Director Mr. Dearen serves a director of the company. Mahmood Razavi 18001 Cowan, Suite L Irvine CA CALIFORNIA 92614 Director Mr. Razavi serves as a director of the company. Randy Werneth 18001 Cowan, Suite L Irvine CA CALIFORNIA 92614 Director Mr. Werneth serves as a director of the company. Pintoo Shah 18001 Cowan, Suite L Irvine CA CALIFORNIA 92614 Executive Officer Mr. Shah serves as an executive officer of the company. Neal Hermanowicz 18001 Cowan, Suite L Irvine CA CALIFORNIA 92614 Executive Officer Mr. Hermanowicz serves as an executive officer of the company. Shinya Miike 18001 Cowan, Suite L Irvine CA CALIFORNIA 92614 Director Mr. Miike serves as a director of the company. Biotechnology Decline to Disclose 06b false 2024-03-12 false true false 25000 1475000 1475000 0 false 7 0 0 300000 true Up to approximately $300,000 of the proceeds of the offering may be used to reimburse officers for out-of-pocket expenses incurred in connection with the offering and to pay officer salaries. false Allevion Therapeutics, Inc. Shahram Moaddeb Shahram Moaddeb Chief Executive Officer 2024-03-26